MHIM
MacNealy Hoover Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-62,675
| Closed | -$983K | – | 72 |
|
|
2019
Q1 | $983K | Buy |
62,675
+1,900
| +3% | +$29.8K | 0.76% | 45 |
|
|
2018
Q4 | $937K | Sell |
60,775
-4,975
| -8% | -$76.7K | 0.81% | 44 |
|
|
2018
Q3 | $1.42M | Sell |
65,750
-200
| -0.3% | -$4.31K | 1.04% | 41 |
|
|
2018
Q2 | $1.6M | Sell |
65,950
-1,150
| -2% | -$28K | 1.25% | 31 |
|
|
2018
Q1 | $1.15M | Sell |
67,100
-1,100
| -2% | -$18.8K | 0.92% | 42 |
|
|
2017
Q4 | $1.29M | Sell |
68,200
-4,825
| -7% | -$91.4K | 0.93% | 41 |
|
|
2017
Q3 | $1.29M | Buy |
73,025
+62,525
| +595% | +$1.1M | 0.92% | 41 |
|
|
2017
Q2 | $349K | Buy |
10,500
+445
| +4% | +$14.8K | 0.27% | 66 |
|
|
2017
Q1 | $323K | Sell |
10,055
-1,700
| -14% | -$54.6K | 0.25% | 65 |
|
|
2016
Q4 | $426K | Sell |
11,755
-1,425
| -11% | -$51.6K | 0.33% | 61 |
|
|
2016
Q3 | $607K | Hold |
13,180
| – | – | 0.49% | 56 |
|
|
2016
Q2 | $662K | Buy |
13,180
+250
| +2% | +$12.6K | 0.53% | 57 |
|
|
2016
Q1 | $692K | Buy |
12,930
+75
| +0.6% | +$4.01K | 0.56% | 56 |
|
|
2015
Q4 | $844K | Buy |
12,855
+200
| +2% | +$13.1K | 0.71% | 52 |
|
|
2015
Q3 | $715K | Hold |
12,655
| – | – | 0.64% | 56 |
|
|
2015
Q2 | $748K | Sell |
12,655
-200
| -2% | -$11.8K | 0.61% | 56 |
|
|
2015
Q1 | $801K | Hold |
12,855
| – | – | 0.69% | 55 |
|
|
2014
Q4 | $739K | Sell |
12,855
-200
| -2% | -$11.5K | 0.63% | 56 |
|
|
2014
Q3 | $702K | Sell |
13,055
-250
| -2% | -$13.4K | 0.62% | 59 |
|
|
2014
Q2 | $698K | Sell |
13,305
-300
| -2% | -$15.7K | 0.61% | 55 |
|
|
2014
Q1 | $719K | Sell |
13,605
-600
| -4% | -$31.7K | 0.64% | 53 |
|
|
2013
Q4 | $569K | Buy |
+14,205
| New | +$569K | 0.53% | 59 |
|